ArticleFrontiers in immunology2026

Optimal timing of surgery after conversion therapy for initially unresectable hepatocellular carcinoma: a multicenter study integrating major pathological response and treatment duration.

Siming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.